Records containing: Stage III Adult Soft Tissue Sarcoma

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2014-03-17
A Phase II Clinical and Correlative Study of BAY 43-9006 (Sorafenib) IND 69,896 in Sarcoma
CLINICAL_TRIALS study record update · 2014-01-30
A Phase II Clinical Trial of Angiotensin 1-7 For the Second or Third Line Treatment of Patients With Metastatic or Unresectable Sarcomas
CLINICAL_TRIALS study record update · 2014-01-20
A Multicenter Phase II Study of Sorafenib (BAY43-9006) in Non-GIST Sarcomas
CLINICAL_TRIALS study record update · 2013-11-21
A Phase II Study of Suberoylanilide Hydroxamic Acid and Bortezomib in Advanced Soft Tissue Sarcomas
CLINICAL_TRIALS study record update · 2013-06-27
Phase II Study of Neoadjuvant Doxorubicin and Ifosfamide, Radiotherapy, and Surgical Resection in Patients With Primary or Recurrent Retroperitoneal Sarcoma
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2013-06-17
Randomized Study of Vincristine, Actinomycin-D, and Cyclophosphamide (VAC) Versus VAC Alternating With Vincristine, Topotecan and Cyclophosphamide for Patients With Intermediate Risk Rhabdomyosarcoma
CLINICAL_TRIALS study record update · 2013-06-04
A Phase II Study of Perifosine in Soft Tissue Sarcoma
CLINICAL_TRIALS study record update · 2013-06-04
A Trial of CCI-779 in Patients With Soft Tissue Sarcoma.
CLINICAL_TRIALS study record update · 2013-01-16
Does Hypoxia Predict Radiation/Surgical Tumor Response/A Correlative Trial of EF5, an Agent for the Detection of Tumor Hypoxia
CLINICAL_TRIALS study record update · 2013-01-16
Distribution Of The Photosensitizer Motexafin Lutetium And Hypoxia In Patients With Malignancies